Aids in the evaluation of liver function and intrahepatic cholestasis of pregnancy. Use to monitor patients on bile acid therapy. This assay is not useful for the diagnosis of inborn errors of bile acid metabolism.
Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
Tue, Thu, Sat
New York DOH Approval Status
Patient should fast for a minimum of eight hours prior to specimen collection.
Plain red or serum separator tube.
After clot formation, centrifuge specimen and pour off serum into a transport tube. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.2 mL)
Refrigerated. Store specimen refrigerated or frozen.
Ambient: 8 hours; Refrigerated: 2 weeks; Frozen: 3 months
7 years and older:
Cholic acid (CA) 0-1.9 µmol/L
Chenodeoxycholic acid (CDC) 0-3.4 µmol/L
Deoxycholic acid (DCA) 0-2.5 µmol/L
Ursodeoxycholic acid (UDC) 0-1.0 µmol/L
Total 0-7.0 µmol/L
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Reference intervals were derived using samples obtained after an overnight fast.
|Component Test Code*||Component Chart Name||LOINC|
|0092611||Bile Acids - Cholic Acid||30518-5|
|0092612||Bile Acids - Deoxycholic Acid||30520-1|
|0092613||Bile Acids - Chenodeoxycholic Acid||30519-3|
|0092614||Total Bile Acids||14628-2|
|0093240||Bile Acids - Ursodeoxycholic Acid||55159-8|
- Bile Salts
- Chenodeoxycholic Acid
- Cholic Acid
- Deoxycholic Acid
- Fractionated Bile Acids
- Ursodeoxycholic Acid (UDC)